Clinical trials
Active, not recruiting Rhabdomyosarcoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| Baylor College of Medicine | 3 |
| St. Jude Children's Research Hospital | 3 |
| Seattle Children's Hospital | 2 |
| Cellectar Biosciences, Inc. | 1 |
| Children's Oncology Group | 1 |
| Emory University | 1 |
| GlaxoSmithKline | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 25 |
| Sarcoma | 16 |
| Osteosarcoma | 15 |
| Neuroblastoma | 14 |
| Sarcoma, Ewing | 14 |
| Rhabdoid Tumor | 13 |
| Wilms Tumor | 13 |
| Hepatoblastoma | 12 |
| Ependymoma | 11 |
| Medulloblastoma | 11 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.